RFP Financial Group’s Takeda Pharmaceutical TAK Stock Holding History

RFP Financial Group’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-839	Closed	-$10.9K	–	714
2024 Q2	$10.9K	Buy	839 +356	+74%	+$4.71K	﹤0.01%	439
2024 Q1	$6.71K	Sell	483 -341	-41%	-$4.96K	﹤0.01%	465
2023 Q4	$11.8K	Buy	824 +736	+836%	+$10.4K	﹤0.01%	388
2023 Q3	$1.36K	Hold	88	–	–	﹤0.01%	728
2023 Q2	$1.38K	Hold	88	–	–	﹤0.01%	767
2023 Q1	$1.45K	Hold	88	–	–	﹤0.01%	568
2022 Q4	$1.37K	Buy	+88	New	+$1.23K	﹤0.01%	729

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

RFP Financial Group's TAK Position: Q3 2024 in Review

RFP Financial Group sold out of Takeda Pharmaceutical (TAK) in Q3 2024, closing a stake of 839 shares — an estimated $10.9K sold.

RFP Financial Group first reported a position in TAK in Q4 2022 and held it in 7 quarters. The position peaked at $11.8K in Q4 2023. 298 funds tracked by Wall St. Rank hold TAK as of Q3 2024.

RFP Financial Group reported no remaining Takeda Pharmaceutical position as of Q3 2024 after selling out during the quarter.
RFP Financial Group sold 839 Takeda Pharmaceutical shares in Q3 2024, an estimated $10.9K.
RFP Financial Group first reported a position in Takeda Pharmaceutical in Q4 2022 and held it in 7 quarters.
RFP Financial Group's Takeda Pharmaceutical position peaked at $11.8K in Q4 2023.
298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.